Does Anti Platelet Agents Interact with Apalutamide?
Anti Platelet Agents and Apalutamide have a moderate drug interaction according to U.S. FDA drug labeling data. Apalutamide induces P-glycoprotein and decreases exposure of P-gp substrates, which may decrease their effectiveness. Consider alternative agents or monitor for loss of activity. The mechanism involves apalutamide induces p-glycoprotein, decreasing substrate exposure. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Anti Platelet Agents and Apalutamide occurs because apalutamide induces p-glycoprotein, decreasing substrate exposure. Clinically, this means apalutamide induces p-glycoprotein and decreases exposure of p-gp substrates, which may decrease their effectiveness. consider alternative agents or monitor for loss of activity. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Anti Platelet Agents and your doctor is considering prescribing Apalutamide (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider